Highly specific and sensitive gene panels for cancer screening: First application of only-normal and only-tumor genes
Gabriel Gil , Claudia Carricarte , Julio C. Drake-Pérez , Yasser Perera , Augusto Gonzalez
Tumor Discovery ›› 2025, Vol. 4 ›› Issue (3) : 58 -69.
The traditional paradigm of gene expression dysregulation emphasizes log-fold differential expression, with differentially expressed genes presumed to play key roles in relevant biological processes. In cancer, where normal tissue and tumors occupy non-overlapping regions in gene expression space, we propose an alternative and broader framework based on differentially expressed only-tumor genes (T-genes) and non-differentially dysregulated only-normal genes (N-genes). N-genes exhibit expression intervals found exclusively in normal samples, while T-genes display intervals exclusive to tumor samples. These N- and T-genes serve as markers that can be combined into small gene panels capable of perfectly discriminating between normal and tumor tissues. In most cases, these panels highlight biologically significant properties, such as altered glutamine metabolism in tumors. We provide an inventory of perfect gene panels for 12 cancer types, with potential applications in diagnostics and immunotherapy. Significance: Highly specific and sensitive combinatorial gene panels for the identification of 12 types of solid tumors in humans were derived from RNA sequencing expression profiles reported by The Cancer Genome Atlas network (https://www.cancer.gov/ccg/research/genome-sequencing/tcga). The corresponding software is available at the GitHub repository https://github.com/gabriel-gil/GenePan. This study revisits the concept of cancer-related gene expression dysregulation by introducing N-genes and T-genes as novel dysregulation patterns that can be leveraged in diagnosis, tumor classification, and therapeutic interventions.
Cancer / Combinatorial gene panel / Expression dysregulation / Only-normal genes / Only-tumor genes
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
The Cancer Genome Atlas Research Network, |
| [5] |
|
| [6] |
The Cancer Genome Atlas Research Network. The Cancer Genome Atlas. 2006. Available from: https://www.cancer.gov/tcga [Last accessed on 2025 Apr 15]. |
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
World Health Organization. Cancer. Available from: https://www.who.int/news-room/factsheets/detail/cancer [Last accessed on 2025 April 15]. |
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
/
| 〈 |
|
〉 |